PharmEasy parent API Holdings pulls Rs 6,250 cr IPO, weighs rights issue from Prosus, TPG, Temasek
API Holdings has withdrawn the DRHP for its Rs 6,250 crore IPO originally filed in November 2021, citing weak market conditions. The Mumbai-based online pharmacy is now exploring a rights issue backed by existing investors Prosus, TPG and Temasek to shore up capital.
API Holdings has withdrawn the DRHP for its Rs 6,250 crore IPO originally filed in November 2021, citing weak market conditions. The Mumbai-based online pharmac
Moneycontrol · 5/26/2026, 9:46:28 PM · Ask about this →